Pharsight

Drugs that contain Budesonide; Formoterol Fumarate Dihydrate

1. Symbicort patents expiration

SYMBICORT's oppositions filed in EPO
SYMBICORT Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6641800 ASTRAZENECA Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane
Sep, 2012

(11 years ago)

US5972919 ASTRAZENECA Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders, as well as its use and the preparation thereof
Dec, 2012

(11 years ago)

US5674860 ASTRAZENECA Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders
Oct, 2014

(9 years ago)

US6123924 ASTRAZENECA Pressurized aerosol inhalation compositions
Sep, 2017

(6 years ago)

US6123924

(Pediatric)

ASTRAZENECA Pressurized aerosol inhalation compositions
Mar, 2018

(6 years ago)

US8461211 ASTRAZENECA Use for budesonide and formoterol
Sep, 2018

(5 years ago)

US7897646 ASTRAZENECA Use for budesonide and formoterol
Sep, 2018

(5 years ago)

US7367333 ASTRAZENECA Inhalation device
Nov, 2018

(5 years ago)

US8461211

(Pediatric)

ASTRAZENECA Use for budesonide and formoterol
Mar, 2019

(5 years ago)

US7897646

(Pediatric)

ASTRAZENECA Use for budesonide and formoterol
Mar, 2019

(5 years ago)

US7367333

(Pediatric)

ASTRAZENECA Inhalation device
May, 2019

(4 years ago)

US7967011 ASTRAZENECA Inhalation device
Aug, 2021

(2 years ago)

US7967011

(Pediatric)

ASTRAZENECA Inhalation device
Feb, 2022

(2 years ago)

US11311558 ASTRAZENECA Composition for inhalation
Jan, 2023

(1 year, 2 months ago)

US10166247 ASTRAZENECA Composition for inhalation
Jan, 2023

(1 year, 2 months ago)

US8575137 ASTRAZENECA Composition for inhalation
Jan, 2023

(1 year, 2 months ago)

US7759328 ASTRAZENECA Composition for inhalation
Jan, 2023

(1 year, 2 months ago)

US8143239 ASTRAZENECA Composition for inhalation
Jan, 2023

(1 year, 2 months ago)

US7759328

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(8 months ago)

US8575137

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(8 months ago)

US8143239

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(8 months ago)

US11311558

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(8 months ago)

US10166247

(Pediatric)

ASTRAZENECA Composition for inhalation
Jul, 2023

(8 months ago)

US8875699 ASTRAZENECA Inhaler cap strap
Nov, 2024

(6 months from now)

US8875699

(Pediatric)

ASTRAZENECA Inhaler cap strap
May, 2025

(1 year, 19 days from now)

US7587988 ASTRAZENECA Inhaler device counter
Apr, 2026

(1 year, 11 months from now)

US7587988

(Pediatric)

ASTRAZENECA Inhaler device counter
Oct, 2026

(2 years from now)

US8387615 ASTRAZENECA Inhaler cap strap
Mar, 2027

(2 years from now)

US8387615

(Pediatric)

ASTRAZENECA Inhaler cap strap
Sep, 2027

(3 years from now)

US8528545 ASTRAZENECA Inhaler device that reduces the risk for miscounting a dosage
Oct, 2028

(4 years from now)

US8616196 ASTRAZENECA Inhalation device and a method for assembling said inhalation device
Apr, 2029

(4 years from now)

US8528545

(Pediatric)

ASTRAZENECA Inhaler device that reduces the risk for miscounting a dosage
Apr, 2029

(4 years from now)

US8616196

(Pediatric)

ASTRAZENECA Inhalation device and a method for assembling said inhalation device
Oct, 2029

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-582) Feb 27, 2012
M(M-210) Sep 11, 2020
New Patient Population(NPP) Jan 27, 2020
M(M-214) Dec 20, 2020
Pediatric Exclusivity(PED) Jul 27, 2020

Market Authorisation Date: 21 July, 2006

Treatment: Use for the treatment of asthma; Use for the treatment of chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema; Use for maintenance treatment of chronic obstructive...

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of SYMBICORT before it's drug patent expiration?
More Information on Dosage

SYMBICORT family patents

Family Patents